Literature DB >> 7847562

Control of peripartal collagenolysis in the human chorion-decidua.

G D Bryant-Greenwood1, S Y Yamamoto.   

Abstract

OBJECTIVE: This study was designed to observe the in vivo status of chorion-decidua gene expression for some major metalloproteinases, an inhibitor (tissue inhibitor of metalloproteinase-1), and an activator (tissue plasminogen activator) and the hormone relaxin at accessible time points in the peripartal period. STUDY
DESIGN: Chorion-decidua from patients at cesarean section with and without labor and after spontaneous labor and delivery was used for preparation of poly (A)+ ribonucleic acid and quantitative Northern analyses with a series of oligo and complementary deoxyribonucleic acid probes.
RESULTS: In the period designated as the period before parturition, relaxin and matrix metalloproteinase-1 (interstitial collagenase) gene expression were relatively high, reflecting the controlled loss of amniotic collagen necessary for fetal membrane expansion without rupture as the uterine volume increases. When active labor has begun, but before delivery, matrix metalloproteinase-3 (stromelysin) and matrix metalloproteinase-9 (type V collagenase) gene levels significantly increased. After normal spontaneous labor and delivery, tissue plasminogen activator and tissue inhibitor of metalloproteinase-1 messenger ribonucleic acids significantly increased, together with a marginally increased expression of the genes for matrix metalloproteinase-1, matrix metalloproteinase-2 (type IV collagenase), and relaxin.
CONCLUSION: The expression of the genes for some major collagenolytic enzymes, an inhibitor, activator, and relaxin in the chorion-decidua, is different at the different stages of parturition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7847562     DOI: 10.1016/0002-9378(95)90085-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Preterm premature rupture of membranes without labor is not associated with increased levels of matrix metalloproteinase-9 protein.

Authors:  D L Draper; M J Kush; W Donohoe; J Janosky; J J Latimer; R P Heine
Journal:  Prenat Neonatal Med       Date:  2001-08-01

Review 2.  Preterm prelabor rupture of the membranes: A disease of the fetal membranes.

Authors:  Ramkumar Menon; Lauren S Richardson
Journal:  Semin Perinatol       Date:  2017-08-12       Impact factor: 3.300

3.  The matrix metalloproteases and endothelin-1 in infection-associated preterm birth.

Authors:  Nicole S Olgun; Sandra E Reznik
Journal:  Obstet Gynecol Int       Date:  2010-07-26

4.  Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery.

Authors:  Ceyda Oner; Frederick Schatz; Gulnur Kizilay; William Murk; Lynn F Buchwalder; Umit A Kayisli; Aydin Arici; Charles J Lockwood
Journal:  J Clin Endocrinol Metab       Date:  2007-10-16       Impact factor: 5.958

5.  Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.

Authors:  Inge Tency; Hans Verstraelen; Ivo Kroes; Gabriële Holtappels; Bruno Verhasselt; Mario Vaneechoutte; Rita Verhelst; Marleen Temmerman
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

6.  Sphingosine kinase: a novel putative target for the prevention of infection-triggered preterm birth.

Authors:  Vibhuti Vyas; Charles R Ashby; Sandra E Reznik
Journal:  Obstet Gynecol Int       Date:  2013-05-26

7.  Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants.

Authors:  Digna R Velez; Stephen J Fortunato; Poul Thorsen; Salvatore J Lombardi; Scott M Williams; Ramkumar Menon
Journal:  PLoS One       Date:  2008-09-26       Impact factor: 3.240

8.  Serum Decorin, Biglycan, and Extracellular Matrix Component Expression in Preterm Birth.

Authors:  Jenna M Mennella; Lori A Underhill; Sophia Collis; Geralyn M Lambert-Messerlian; Richard Tucker; Beatrice E Lechner
Journal:  Reprod Sci       Date:  2020-08-17       Impact factor: 3.060

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.